Summary by Futu AI
Pharmaceutical Biotechnology Limited announced that a Board Meeting will be held on 26 March 2024 (Tuesday) to consider and approve the Group's annual results for the year ended 31 December 2023 and their publication. The meeting will be chaired by Dr. Li Keung, Chairman, and attended by Executive Directors Dr. Chan Chi Shing and Dr. Zhou Wai Cheong, Non-Executive Directors Dr. Li Keung, Dr. Wu Yibing and Mr. Cao Yen-ling, as well as Independent Non-Executive Directors Mr. William Robert Keller, Mr. Kenneth Walton Hitchner III, Mr. Dai Kwok Leung and Dr. Chan. The main agenda of the meeting is to review and approve the company's annual results report.